Filing Flows › Zymeworks (ZYME) › Q4 2024
Zymeworks (ZYME) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 5, 2025
Zymeworks (ZYME) reported revenue of $31.0M for the fourth quarter 2024 (Q4 2024), +83% from a year earlier and +94% from the quarter before. Operating margin was -71.6%, net loss $23.5M (75.8% of revenue).
Zymeworks, Q4 2024: revenue $31.0M (+83% year over year), operating margin -71.6%, net loss $23.5M, operating cash flow −$41.5M. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $31.0M | +94% | +83% |
| Operating profit | −$22.2M | — | — |
| Net earnings | −$23.5M | — | — |
| Operating cash flow | −$41.5M | — | — |
What changed
Revenue was $31.0M in Q4 2024, up 83% year over year and up 94% from the previous quarter.
Operating costs exceeded revenue by $22.2M, an operating margin of -71.6%. Total costs grew 32% against revenue growth of 83%. The fastest-growing cost line was Research & development (+45%). The quarter ended with a net loss of $23.5M, narrower than the previous quarter's $29.9M loss. Non-operating items added $4.4M, -25% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$41.5M. Non-cash charges added back $3.0M of depreciation and amortization and $5.0M of share-based compensation. Working capital and other items used $26.0M. Capital expenditures of $314K exceeded it, leaving free cash flow of −$41.8M.
Questions
What was Zymeworks' revenue in the fourth quarter 2024?
Zymeworks (ZYME) reported revenue of $31.0M for the fourth quarter 2024 (Q4 2024), +83% from a year earlier and +94% from the quarter before.
Was Zymeworks profitable in the fourth quarter 2024?
Operating loss was $22.2M (-71.6% of revenue) and net loss $23.5M.
Source: Zymeworks 10-K on SEC EDGAR.